Actavis Group PTC ehf. Zentiva, joint-stock company

The medicine is used for the treatment and control of benign prostatic hyperplasia (enlarged prostate). It helps to reduce its size, improve urine flow, relieve symptoms, and reduce the risk of acute urinary retention or the need for surgery.

Dosage form: tablets, film-coated

ATC: G04CB01